As outcry builds over Trump cuts to NIH payments, drugmakers are MIA The biopharma industry, a major beneficiary of academic research, has largely stayed quiet

https://www.statnews.com/2025/02/11/nih-payment-costs-trump-pharma-industry-biotech/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz-89PRPyp2A_vdbvjPKID3BI2crvduSetOOKfjuemHFSA0yXyPkyHEn9e6mXeCrsEWu-LqbTERDwW8qSWqObHHlJSd9hYA&_hsmi=346888503&utm_content=346888503&utm_source=hs_email A judge blocks Trump’s NIH funding cuts & universities react A federal judge has ordered a nationwide temporary pause on plans by the NIH to substantially slash research overhead payments to universities, medical centers, and other grant recipients. The pause came late Monday after the same judge granted another temporary restraining order in response to a lawsuit filed by attorneys general from 22 states — meaning it only applied to those states. In response to the court orders, several large research universities reversed policies they’d enacted less than 24 hours before to mitigate budget shortfalls due to the cuts. Still, scientists told STAT that the uncertainty has made it much more difficult to justify the time it takes to assemble a research proposal. Read the latest update. And if you’re wondering where the biotech industry is in all of this, we wondered that, too. STAT’s Adam Feuerstein wrote yesterday that as outcry builds over these cuts, drugmakers are MIA. https://www.statnews.com/2025/02/11/judge-orders-nationwide-halt-trump-nih-research-indirect-costs/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz--cTTpGaezEu7Xj6lHW5gVAEKwhn0io4QVLyX-nub-_Bb2F_Fw2Buz-nS5YZmrxhwgzyfqnWvK-P9DdC-AZyNX5WKKEPA&_hsmi=346888503&utm_content=346888503&utm_source=hs_email